| Accucare Home Nursing Inc | |
| 1999 Sproul Road Suite 1, Broomall, Pennsylvania 19008 | |
| (610) 353-7360 | |
| Not Available |
| Name | Accucare Home Nursing Inc |
|---|---|
| Location | 1999 Sproul Road Suite 1, Broomall, Pennsylvania |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 397623 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 18018 |
| NPI Number | 1427429067 |
| Organization Name | COZY SENIOR CARE, LLC. |
| Address | 1999 Sproul Rd, Suite 14, Broomall, PA 19008 |
| Phone Number | 610-635-8549 |
News Archive
The Nigerian government believes that by 2013 malaria will cease to be a major public health problem in the country because families will have universal access to prevention and treatment, which will ultimately lead to malaria eradication in Nigeria, according to a document prepared by the National Malaria Control Program of the Federal Ministry of Health in Abuja, Nigeria, Xinhua reports.
A pioneer in the field of epigenetics who has been spearheading the use of genome-wide technology for epigenetics research, a researcher who has revealed a weakness in the tuberculosis bacterium that makes it more susceptible to antibiotics, and a scientist who seeks to revolutionize new methods for toxicological testing to improve human health and reduce animal testing have received Director's Awards from the National Institutes of Health.
Spectrum Pharmaceuticals, Inc., a commercial stage biotechnology company with a primary focus in oncology, today announced that clinical data on ZEVALIN (ibritumomab tiuxetan) was presented at the 51st Annual Meeting of the American Society of Hematology (ASH), which was held December 5-8, 2009 at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
Researchers at the University of Hong Kong found that Clofazimine, a lipophilic antimicrobial riminophenazine dye used in combination with agents like rifampicin and dapsone to treat leprosy, inhibits coronaviruses, including the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19 disease.
› Verified 7 days ago
| Quality Rating: | Not Available* |
| * This measure currently does not have data or provider has been certified/recertified for less than 6 months. | |
News Archive
The Nigerian government believes that by 2013 malaria will cease to be a major public health problem in the country because families will have universal access to prevention and treatment, which will ultimately lead to malaria eradication in Nigeria, according to a document prepared by the National Malaria Control Program of the Federal Ministry of Health in Abuja, Nigeria, Xinhua reports.
A pioneer in the field of epigenetics who has been spearheading the use of genome-wide technology for epigenetics research, a researcher who has revealed a weakness in the tuberculosis bacterium that makes it more susceptible to antibiotics, and a scientist who seeks to revolutionize new methods for toxicological testing to improve human health and reduce animal testing have received Director's Awards from the National Institutes of Health.
Spectrum Pharmaceuticals, Inc., a commercial stage biotechnology company with a primary focus in oncology, today announced that clinical data on ZEVALIN (ibritumomab tiuxetan) was presented at the 51st Annual Meeting of the American Society of Hematology (ASH), which was held December 5-8, 2009 at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
Researchers at the University of Hong Kong found that Clofazimine, a lipophilic antimicrobial riminophenazine dye used in combination with agents like rifampicin and dapsone to treat leprosy, inhibits coronaviruses, including the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19 disease.
› Verified 7 days ago
News Archive
The Nigerian government believes that by 2013 malaria will cease to be a major public health problem in the country because families will have universal access to prevention and treatment, which will ultimately lead to malaria eradication in Nigeria, according to a document prepared by the National Malaria Control Program of the Federal Ministry of Health in Abuja, Nigeria, Xinhua reports.
A pioneer in the field of epigenetics who has been spearheading the use of genome-wide technology for epigenetics research, a researcher who has revealed a weakness in the tuberculosis bacterium that makes it more susceptible to antibiotics, and a scientist who seeks to revolutionize new methods for toxicological testing to improve human health and reduce animal testing have received Director's Awards from the National Institutes of Health.
Spectrum Pharmaceuticals, Inc., a commercial stage biotechnology company with a primary focus in oncology, today announced that clinical data on ZEVALIN (ibritumomab tiuxetan) was presented at the 51st Annual Meeting of the American Society of Hematology (ASH), which was held December 5-8, 2009 at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
Researchers at the University of Hong Kong found that Clofazimine, a lipophilic antimicrobial riminophenazine dye used in combination with agents like rifampicin and dapsone to treat leprosy, inhibits coronaviruses, including the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19 disease.
› Verified 7 days ago
Millenium Home Health Care, Inc Location: 370 Reed Road, Suite 319, Broomall, Pennsylvania 19008 Ratings: Phone: (610) 543-4126 | |
Accucare Home Nursing Inc Location: 1999 Sproul Road Suite 1, Broomall, Pennsylvania 19008 Ratings: NA Phone: (610) 353-7360 |